The Applied Molecular Profiling Laboratory (AMPL) consolidates expertise from scientists and clinicians at the Princess Margaret Hospital (PMH) / Ontario Cancer Institute (OCI) for the molecular profiling of tumour samples and tumour response in clinical and pre-clinical studies using cutting-edge technologies.
AMPL offers one-stop shopping for tailored services in Cytomics, Genomics and Pharmacokinetics, providing standard operating procedures from start (specimen collection) to finish (generating results). AMPL has provided services to researchers, clinical trial investigators, PMH Drug Development Program (DDP), the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG), and industry sponsored projects.
|
 |
Consultation on design and budgets for biomarker analysis in clinical protocols and research projects |
| |
Cytomics |
| |
|
Molecular histo-pathology |
| |
|
Advanced image analysis for immunohistochemistry and immunofluorescence |
| |
|
Flow cytometry R&D, single-cell signal activation analysis |
| |
|
ELISA |
|
|
Genomics |
| |
|
FISH |
| |
|
Gene mutation (gene sequencing, real-time qPCR, MassARRAY-Sequenom) |
| |
|
Pharmacogenomics (single nucleotide polymorphisms, SNPs) |
|
|
Pharmacokinetics |
| |
|
HPLC |
| |
| Please visit the AMPL web site for more information . |
|
|
Contact
|
Nhu-An Pham
Manager
416-946-4570
|
| |
| Co-Directors |
| Drs. Eric Chen, Suzanne Kamel-Reid, David Hedley, Geoffrey Liu, Malcolm Moore, Jeremy Squire & Ming-Sound Tsao |
| |
| Location |
Princess Margaret Hospital / Ontario Cancer Institute
Room 7-624
610 University Avenue
Toronto, ON
M5G 2M9 |
|
